FILTER

FILTERED INTERVIEW RESULTS

Mining
Chile

Pascal Zappone

MANAGING DIRECTOR, SCANIA CHILE
Scania Chile explains its offering for the mining sector.
Mining
Chile

Pablo Varela

MANAGING DIRECTOR – LATIN AMERICA, AGGREKO
Aggreko discusses the rise of solar energy, and power options for mining
Mining
Chile

Iván Rayo

GENERAL MANAGER, JRI
JRI describes the trends in Chile’s mining engineering sector
Mining
Chile

Michael W. Scherb

FOUNDER & CEO, APPIAN CAPITAL ADVISORY LLP
Michael Scherb discusses Appian Capital Advisory’s approach to mining finance
Mining
Chile

Philippe Hemmerdinger

PRESIDENT, ASSOCIATION OF INDUSTRIAL MINING SUPPLIERS (APRIMIN)
Chile’s Association of Industrial Mining Suppliers (APRIMIN)
Mining
Chile

Manuel Viera

PRESIDENT, CHILEAN MINING CHAMBER (CÁMARA MINERA DE CHILE)
Manuel Viera discusses the nationalisation proposal by Chile’s Environmental Commission of the Constitutional Convention
Mining
Chile

Michael Cullen & Daniela Cuellar

MANAGING DIRECTOR – LATIN AMERICA (MC) & SENIOR CONSULTANT (DC), FTI CONSULTING
FTI Consulting analyses how evolving political risk in Chile relates to mining
Mining
Chile

Timothy Beale

DIRECTOR, PAMPA METALS
Timonthy Beale outlines Pampa Metals exploration plans in Chile for 2022
Mining
Chile

Alex Black

PRESIDENT & CEO, RIO2 LIMITED
Alex Black discusses development at Rio2’s Fenix Gold project in Chile
Peru
Mexico
Chile

Jatyr Drudi Junior

VP NALCO WATER HEAVY & DOWNSTREAM – LATIN AMERICA, ECOLAB
"Global Chemical is our new strategic business unit, leveraging 100 years of Ecolab’s water and process experience to create new, streamlined approaches for the chemical industry that include the use of digital ecosystems combined with circular economy expertise."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL